Improving Antiretroviral Therapy Supply in Uganda
Author Information
Author(s): Ricarda Windisch, Peter Waiswa, Florian Neuhann, Florian Scheibe, Don de Savigny
Primary Institution: Swiss Tropical and Public Health Institute
Hypothesis
Are health systems in Uganda being strengthened to sustain access to antiretroviral therapy?
Conclusion
The study indicates that the opportunity to use investments in antiretroviral therapy for strengthening the health system has not been fully realized.
Supporting Evidence
- By the end of 2009, 200,400 people were receiving antiretroviral therapy in Uganda.
- 95% of the national response to ART is currently covered by donor funds.
- Only 27% of hospitals and about 40% of other health facilities received the quantities of essential drugs they ordered.
Takeaway
This study looks at how Uganda manages the supply of HIV treatment and finds that there are many problems that make it hard for people to get the medicine they need.
Methodology
The study used the WHO health systems framework, combining literature review, key informant interviews, and observations at health service delivery levels.
Potential Biases
Potential bias from reliance on self-reported data from health facilities and stakeholders.
Limitations
The study may not capture all local variations in health system performance across different districts.
Participant Demographics
The study focused on health facilities in Iganga District, which has a population of around 650,000.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website